Open Orphan - New Contract and Directorate Change
ORPH
Mon, 04 May 2020, 12:30pm BST
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
https://www.openorphan.com
Open Orphan, the rapidly growing specialist CRO pharmaceutical services company announces the signing of a new contract with a US biotechnology Company and Cathal Friel, Executive Chairman also announces that Trevor Phillips is standing down as CEO.
